ArticlePharmaceutical research2016
Retraction Note: RGD peptide-pegylated PLLA nanoparticles containing epirubicin hydrochloride exhibit receptor-dependent tumor trafficking in vitro and in vivo.
No numbers read from the abstract.
ArticlePharmaceutical research2016
No numbers read from the abstract.